Microsoft announced AI for Health, a new $40 million program which is part of the AI for Good initiative that will leverage artificial intelligence technology to “empower researchers and organizations addressing some of the world’s toughest challenges in health.”

Roivant Sciences – helmed by biotech billionaire Vivek Ramaswamy – launched a new subsidiary, Lokavant, a technology company with the important mission of ensuring that no clinical trial fails due to operational error.

Flagship Pioneering launched Cellarity, focused on studying and altering cell behaviors as a means of drug development.

Foamix Pharmaceuticals is merging with Menlo Therapeutics to become a biopharma company focusing on dermatology.

AstraZeneca is significantly expanding the company’s footprint in China with the establishment of a global R&D center and launch of a $1 billion fund aimed at supporting that nation’s healthcare sector.

Century Therapeutics, a startup founded by Versant Ventures, launched with $250 million in hand and a focus on developing induced pluripotent stem cell-based therapies for the treatment of hematologic and solid malignancies.

The Inception Company, a technology-driven production company, and WEGO Health, the premiere network of patient opinion leaders and health influencers, announced the launch of “Patient Co-Lab.”

Fitbit launched the company’s cheapest smartwatch to defend its position as the second-largest seller of smartwatches after Apple.

New York City-based HiberCell launched with a $60.75 million Series A funding, led by ARCH Venture Partners.

Gotham Therapeutics launched in New York with a $54 million Series A financing. The round was co-led by founding investor Versant Ventures, Forbion, and S.R. One.